Undecided on this one, Pfizer CEO says the corporate is ready to distribute “tons of of hundreds of doses,

  • the agency is more likely to have the important thing information from its late-stage trial by the top of October
  • if FDA approval is secured the corporate is ready

Weekend feedback from the top of the corporate. 

100s of 1,000s would not actually lower it. It a begin I assume. 


  • On Saturday, Pfizer submitted a proposal to the FDA to develop the late-stage trial to incorporate as much as 44,000 individuals (from its earlier goal of 30,000)